Skip to content

Mind Body Syndrome (MBS) Therapy for the Treatment of Chronic Pain

Mind Body Syndrome (MBS) Therapy for the Treatment of Chronic Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02117921
Enrollment
20
Registered
2014-04-21
Start date
2014-02-28
Completion date
2016-12-31
Last updated
2024-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Keywords

Mind Body Syndrome, MBS, Chronic Pain

Brief summary

To determine if Mind Body Syndrome (MBS) therapy will reduce or eliminate pain in patients suffering from chronic pain syndromes without organic etiology.

Interventions

BEHAVIORALOne-on-one interview and educational sessions. Reading material for educational series provided.

A one-on-one interview with the patient and the principal investigator and group educational sessions.

Sponsors

Beth Israel Deaconess Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patient 18 \> years old * Chronic pain without clear organic etiology after full evaluation by primary care physician or subspecialist * Pain persistent for a minimum of 3 days a week for the past three months prior to enrollment

Exclusion criteria

* Patients \< 18 years of age * Diagnosed organic disease as cause of pain, such as but not limited to malignancy, neurologic disorder (i.e., amyotrophic lateral sclerosis) * Patients with a diagnosis of significant psychiatric co-morbidities such as schizophrenia and bi-polar disorder. Mild to moderate depression and anxiety will not be considered as exclusions * Pregnancy * Severe depression or recent suicide attempt

Design outcomes

Primary

MeasureTime frameDescription
Brief Pain Inventory Questionnaire4 weeksTo determine if Mind Body Syndrome (MBS) therapy will reduce or eliminate pain in patients suffering from chronic pain syndromes without organic etiology.
SF-12 Health Survey Scoring Demonstration4 weeks

Secondary

MeasureTime frame
SF-12 Health Survey Scoring Demonstration and Brief Pain Inventory Score2 weeks, 4 weeks, 6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026